Yusuf Abrahim, Sarika Sharma, K. Daniel, V. Daniel
{"title":"免疫受病毒性癌症的影响——综述","authors":"Yusuf Abrahim, Sarika Sharma, K. Daniel, V. Daniel","doi":"10.2875/.V1I1.5","DOIUrl":null,"url":null,"abstract":"ABSTRACT- T cell responses that recognize and eradicate cancer cells. However, elimination of cancer by T cells is only one step in the Cancer-Immunity Cycle, which manages the delicate balance between the recognition of onself and the prevention of autoimmunity. Identification of cancer cell T cell inhibitory signals, includingPD-L1, has prompted the development of a new class of cancer immunotherapy that specifically hindersmmune effector inhibition, reinvigorating and potentially expanding preexisting anticancer immune re-sponses. The presence of suppressive factors in the tumor microenvironment may explain the limited activityobserved with previous immune-based therapies and why these therapies may be more effective in combi-nation with agents that target other steps of the cycle. Emerging clinical data suggest that cancer immuno-therapy is likely to become a key part of the clinical management of cancer Keywords- Immunity, Virus ,Cancer, Human Papillomavirus,Therapy.","PeriodicalId":18198,"journal":{"name":"生命科学研究","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2014-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Immunity is Affected by Viral Cancer- A Review\",\"authors\":\"Yusuf Abrahim, Sarika Sharma, K. Daniel, V. Daniel\",\"doi\":\"10.2875/.V1I1.5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"ABSTRACT- T cell responses that recognize and eradicate cancer cells. However, elimination of cancer by T cells is only one step in the Cancer-Immunity Cycle, which manages the delicate balance between the recognition of onself and the prevention of autoimmunity. Identification of cancer cell T cell inhibitory signals, includingPD-L1, has prompted the development of a new class of cancer immunotherapy that specifically hindersmmune effector inhibition, reinvigorating and potentially expanding preexisting anticancer immune re-sponses. The presence of suppressive factors in the tumor microenvironment may explain the limited activityobserved with previous immune-based therapies and why these therapies may be more effective in combi-nation with agents that target other steps of the cycle. Emerging clinical data suggest that cancer immuno-therapy is likely to become a key part of the clinical management of cancer Keywords- Immunity, Virus ,Cancer, Human Papillomavirus,Therapy.\",\"PeriodicalId\":18198,\"journal\":{\"name\":\"生命科学研究\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-11-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"生命科学研究\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2875/.V1I1.5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"生命科学研究","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2875/.V1I1.5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
ABSTRACT- T cell responses that recognize and eradicate cancer cells. However, elimination of cancer by T cells is only one step in the Cancer-Immunity Cycle, which manages the delicate balance between the recognition of onself and the prevention of autoimmunity. Identification of cancer cell T cell inhibitory signals, includingPD-L1, has prompted the development of a new class of cancer immunotherapy that specifically hindersmmune effector inhibition, reinvigorating and potentially expanding preexisting anticancer immune re-sponses. The presence of suppressive factors in the tumor microenvironment may explain the limited activityobserved with previous immune-based therapies and why these therapies may be more effective in combi-nation with agents that target other steps of the cycle. Emerging clinical data suggest that cancer immuno-therapy is likely to become a key part of the clinical management of cancer Keywords- Immunity, Virus ,Cancer, Human Papillomavirus,Therapy.